RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21516013http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21516013http://www.w3.org/2000/01/rdf-schema#comment"The germline R337H mutation in the TP53 gene is considered to be responsible for the increased incidence of adrenocortical tumors (ACTs) in children from Brazil. High level production of hormones in ACTs (>95%) cause virilization alone (60%), Cushing syndrome (<5%), the mixed type (30%), or other rarer manifestations. ACT probably develops owing to events occurring during the final stages of intrauterine life based on the very common early onset of signs and symptoms shortly after birth. In this study, we determined by immunohistochemistry and enzyme assays whether placental alkaline phosphatase (PLAP) is expressed in pediatric ACTs. Immunohistochemical analysis revealed positive p53 expression in 88% of the tested ACTs (29 of 33). PLAP was detected at a slightly lower frequency based on immunohistochemical (17 of 33, 51%) and enzyme activity analyses (9 of 16, 56%). In conclusion, probably at a certain time point during adrenocortical development (end of gestation to early postnatal period), some fetal zone cells survive owing to defective apoptosis and develop into childhood ACT, maintaining some characteristics of the embryonal period, such as PLAP expression. Further studies of PLAP should investigate the functional role, if any, of PLAP in such tumors."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.org/dc/terms/identifier"doi:10.1097/mph.0b013e3182099a80"xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Jenkins J."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Figueiredo B.C."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Zambetti G.P."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Ribeiro R.C."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Pianovski M.A."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Custodio G."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Boechat G.A."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Figueiredo F.R."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/author"Stinghen S.T."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/name"J Pediatr Hematol Oncol"xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/pages"e149-53"xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/title"Placental alkaline phosphatase in pediatric adrenocortical cancer."xsd:string
http://purl.uniprot.org/citations/21516013http://purl.uniprot.org/core/volume"33"xsd:string
http://purl.uniprot.org/citations/21516013http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/21516013
http://purl.uniprot.org/citations/21516013http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/21516013
http://purl.uniprot.org/uniprot/#_B2R7C7-mappedCitation-21516013http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21516013
http://purl.uniprot.org/uniprot/#_P05187-mappedCitation-21516013http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21516013
http://purl.uniprot.org/uniprot/P05187http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/21516013
http://purl.uniprot.org/uniprot/B2R7C7http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/21516013